DICE Therapeutics’ $345 Million Public Offering

Martina Bellini
Tagged:

Wilson Sonsini Goodrich & Rosati advised DICE Therapeutics on the deal.DICE Therapeutics, Inc., a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now